Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1309.TW Stock Summary
Top 10 Correlated ETFs
1309.TW
In the News
1309.TW Financial details
Company Rating
Buy
Market Cap
6.06B
Income
-273.54M
Revenue
15.21B
Book val./share
16.72
Cash/share
6
Dividend
0.5
Dividend %
3.1%
Employees
503
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
-31.88
Forward P/E
53.28
PEG
1.91
P/S
0.43
P/B
0.94
P/C
2.58
P/FCF
51.64
Quick Ratio
2.53
Current Ratio
3.17
Debt / Equity
0.13
LT Debt / Equity
0
-
-
EPS (TTM)
-0.69
EPS next Y
0.29
EPS next Q
-0.11
EPS this Y
-166.35%
EPS next Y
-141.94%
EPS next 5Y
-141.94%
EPS last 5Y
NAN%
Revenue last 5Y
-2.96%
Revenue Q/Q
2.04%
EPS Q/Q
61.11%
-
-
-
-
SMA20
-9.58%
SMA50
-6.22%
SMA100
-8.72%
Inst Own
-
Inst Trans
-
ROA
-2%
ROE
-3%
ROC
-0.03%
Gross Margin
4%
Oper. Margin
-2%
Profit Margin
-1%
Payout
-98%
Shs Outstand
397.59M
Shs Float
249.95M
-
-
-
-
Target Price
-
52W Range
15.0-21.75
52W High
-26.43%
52W Low
+3%
RSI
43.63
Rel Volume
0.44
Avg Volume
691.76K
Volume
302.92K
Perf Week
1.98%
Perf Month
-5.21%
Perf Quarter
-12.22%
Perf Half Y
-12.96%
-
-
-
-
Beta
0.728
-
-
Volatility
0.12%, 0.81%
Prev Close
0.98%
Price
15.45
Change
0%
1309.TW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 45.78 | 38.98 | 52.24 | 45.48 | 38.24 | |
Net income per share | 1.03 | 4.83 | 4.65 | 1.04 | -0.69 | |
Operating cash flow per share | 4.15 | 7.66 | 1.85 | 2.77 | -1.21 | |
Free cash flow per share | 3.91 | 7.32 | 1.53 | 2.42 | -2.17 | |
Cash per share | 4.2 | 7.1 | 8.3 | 7.75 | 6 | |
Book value per share | 11.14 | 15.99 | 19.27 | 18.12 | 16.72 | |
Tangible book value per share | 11.14 | 15.99 | 19.27 | 18.12 | 16.72 | |
Share holders equity per share | 11.14 | 15.99 | 19.27 | 18.12 | 16.72 | |
Interest debt per share | 5.96 | 1.3 | 1.76 | 1.25 | 2.21 | |
Market cap | 3.7B | 13.41B | 13.08B | 8.91B | 6.54B | |
Enterprise value | 4.64B | 11.45B | 11.18B | 6.73B | 5.19B | |
P/E ratio | 9.29 | 6.98 | 7.07 | 21.61 | -23.91 | |
Price to sales ratio | 0.21 | 0.87 | 0.63 | 0.49 | 0.43 | |
POCF ratio | 2.31 | 4.4 | 17.77 | 8.08 | -13.63 | |
PFCF ratio | 2.45 | 4.61 | 21.53 | 9.27 | -7.59 | |
P/B Ratio | 0.86 | 2.11 | 1.71 | 1.24 | 0.98 | |
PTB ratio | 0.86 | 2.11 | 1.71 | 1.24 | 0.98 | |
EV to sales | 0.26 | 0.74 | 0.54 | 0.37 | 0.34 | |
Enterprise value over EBITDA | 5.66 | 4.23 | 4.27 | 8.83 | -20.84 | |
EV to operating cash flow | 2.89 | 3.76 | 15.18 | 6.1 | -10.81 | |
EV to free cash flow | 3.07 | 3.93 | 18.39 | 7.01 | -6.02 | |
Earnings yield | 0.11 | 0.14 | 0.14 | 0.05 | -0.04 | |
Free cash flow yield | 0.41 | 0.22 | 0.05 | 0.11 | -0.13 | |
Debt to equity | 0.52 | 0.08 | 0.09 | 0.07 | 0.13 | |
Debt to assets | 0.28 | 0.05 | 0.06 | 0.05 | 0.1 | |
Net debt to EBITDA | 1.14 | -0.72 | -0.73 | -2.85 | 5.43 | |
Current ratio | 2.11 | 2.74 | 3.11 | 4.42 | 2.87 | |
Interest coverage | 11.93 | 119.17 | 467.29 | 80.97 | -23.26 | |
Income quality | 2.87 | 1.23 | 0.31 | 2.03 | 1.75 | |
Dividend Yield | 0.02 | 0.01 | 0.05 | 0.09 | 0.03 | |
Payout ratio | 0.16 | 0.05 | 0.37 | 1.84 | -0.73 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.06 | -0.04 | -0.17 | -0.13 | 0.8 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 | |
Capex to depreciation | -0.44 | -0.67 | -0.64 | -0.68 | -1.78 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 16.07 | 41.67 | 44.92 | 20.56 | 16.09 | |
ROIC | 0.07 | 0.28 | 0.22 | 0.05 | -0.05 | |
Return on tangible assets | 0.05 | 0.21 | 0.17 | 0.04 | -0.03 | |
Graham Net | 0.05 | 5.07 | 6.91 | 7.12 | 5.37 | |
Working capital | 2.52B | 3.77B | 4.95B | 4.65B | 3.59B | |
Tangible asset value | 4.29B | 6.35B | 7.66B | 7.2B | 6.65B | |
Net current asset value | 1.1B | 3.05B | 4.21B | 3.97B | 3.27B | |
Invested capital | 0.52 | 0.08 | 0.09 | 0.07 | 0.13 | |
Average receivables | 2.68B | 2.3B | 2.44B | 2.16B | 1.83B | |
Average payables | 803.26M | 931.9M | 1.1B | 837.97M | 696.67M | |
Average inventory | 952.9M | 743.57M | 963.31M | 1.07B | 1.03B | |
Days sales outstanding | 47.63 | 53.82 | 45.42 | 35.18 | 46.11 | |
Days payables outstanding | 15.19 | 34.81 | 21.61 | 14.45 | 18.44 | |
Days of inventory on hand | 16.58 | 21.85 | 24.89 | 21.26 | 27.21 | |
Receivables turnover | 7.66 | 6.78 | 8.04 | 10.38 | 7.92 | |
Payables turnover | 24.03 | 10.49 | 16.89 | 25.25 | 19.79 | |
Inventory turnover | 22.01 | 16.7 | 14.66 | 17.16 | 13.42 | |
ROE | 0.09 | 0.3 | 0.24 | 0.06 | -0.04 | |
Capex per share | -0.24 | -0.34 | -0.32 | -0.36 | -0.96 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 9.67 | 8.99 | 9.02 | 10.01 | 10.22 | |
Net income per share | -0.11 | -0.18 | -0.04 | -0.18 | -0.29 | |
Operating cash flow per share | 0.82 | 0.27 | -0.6 | 0.7 | -0.9 | |
Free cash flow per share | 0.75 | 0.16 | -1.21 | 0.61 | -1.05 | |
Cash per share | 7.75 | 6.79 | 5.98 | 6 | 6 | |
Book value per share | 18.12 | 18.15 | 17.25 | 17.27 | 16.72 | |
Tangible book value per share | 18.12 | 18.15 | 17.25 | 17.27 | 16.72 | |
Share holders equity per share | 18.12 | 18.15 | 17.25 | 17.27 | 16.72 | |
Interest debt per share | 1.24 | 0.73 | 1.33 | 0.98 | 2.19 | |
Market cap | 8.91B | 8.43B | 8.03B | 7.12B | 6.54B | |
Enterprise value | 6.73B | 6.2B | 6.29B | 5.25B | 5.19B | |
P/E ratio | -52.35 | -29.39 | -122.02 | -24.7 | -14.42 | |
Price to sales ratio | 2.32 | 2.36 | 2.24 | 1.79 | 1.61 | |
POCF ratio | 27.32 | 78.23 | -33.77 | 25.42 | -18.32 | |
PFCF ratio | 30.04 | 129.67 | -16.7 | 29.18 | -15.67 | |
P/B Ratio | 1.24 | 1.17 | 1.17 | 1.04 | 0.98 | |
PTB ratio | 1.24 | 1.17 | 1.17 | 1.04 | 0.98 | |
EV to sales | 1.75 | 1.73 | 1.75 | 1.32 | 1.28 | |
Enterprise value over EBITDA | -1.26K | -171.19 | 166.18 | -145.26 | -106.88 | |
EV to operating cash flow | 20.65 | 57.52 | -26.44 | 18.74 | -14.53 | |
EV to free cash flow | 22.71 | 95.33 | -13.07 | 21.51 | -12.43 | |
Earnings yield | 0 | -0.01 | 0 | -0.01 | -0.02 | |
Free cash flow yield | 0.03 | 0.01 | -0.06 | 0.03 | -0.06 | |
Debt to equity | 0.07 | 0.04 | 0.08 | 0.06 | 0.13 | |
Debt to assets | 0.05 | 0.03 | 0.06 | 0.04 | 0.1 | |
Net debt to EBITDA | 405.62 | 61.66 | -46.09 | 51.84 | 27.87 | |
Current ratio | 4.42 | 3.79 | 3.92 | 3.17 | 2.87 | |
Interest coverage | -18.37 | -30.63 | -5.5 | -22.9 | -10.19 | |
Income quality | -5.25 | -1.18 | 12.82 | -3.01 | 3.15 | |
Dividend Yield | 0 | 0 | 0 | 0.03 | 0 | |
Payout ratio | 0 | 0 | 0 | -2.76 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.09 | -0.4 | 1.02 | -0.13 | 0.17 | |
Capex to revenue | -0.01 | -0.01 | -0.07 | -0.01 | -0.01 | |
Capex to depreciation | -0.57 | -0.81 | -4.55 | -0.67 | -1.09 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 6.61 | 8.58 | 4.01 | 8.39 | 10.36 | |
ROIC | -0.01 | -0.01 | 0 | -0.01 | -0.01 | |
Return on tangible assets | 0 | -0.01 | 0 | -0.01 | -0.01 | |
Graham Net | 7.12 | 6.69 | 5.72 | 5.76 | 5.37 | |
Working capital | 4.65B | 4.37B | 4.09B | 3.84B | 3.59B | |
Tangible asset value | 7.2B | 7.21B | 6.86B | 6.86B | 6.65B | |
Net current asset value | 3.97B | 3.9B | 3.47B | 3.47B | 3.27B | |
Invested capital | 0.07 | 0.04 | 0.08 | 0.06 | 0.13 | |
Average receivables | 1.94B | 1.76B | 1.79B | 1.94B | 2B | |
Average payables | 755.55M | 802.31M | 815.35M | 852.34M | 889.55M | |
Average inventory | 1.14B | 1.13B | 1.23B | 1.05B | 1.03B | |
Days sales outstanding | 40.8 | 44.95 | 45.01 | 46.97 | 42.56 | |
Days payables outstanding | 16.14 | 24.82 | 17.47 | 23.84 | 17.09 | |
Days of inventory on hand | 23.74 | 34.08 | 29.85 | 21.99 | 25.2 | |
Receivables turnover | 2.21 | 2 | 2 | 1.92 | 2.11 | |
Payables turnover | 5.58 | 3.63 | 5.15 | 3.78 | 5.27 | |
Inventory turnover | 3.79 | 2.64 | 3.01 | 4.09 | 3.57 | |
ROE | -0.01 | -0.01 | 0 | -0.01 | -0.02 | |
Capex per share | -0.07 | -0.11 | -0.61 | -0.09 | -0.15 |
1309.TW Frequently Asked Questions
What is Taita Chemical Company, Limited stock symbol ?
Taita Chemical Company, Limited is a TW stock and trading under the symbol 1309.TW
What is Taita Chemical Company, Limited stock quote today ?
Taita Chemical Company, Limited stock price is $15.45 today.
Is Taita Chemical Company, Limited stock public?
Yes, Taita Chemical Company, Limited is a publicly traded company.